Treatment of Cancer Fifth Edition

Summary:
Since the first edition was published in 1982, Treatment of Cancer has become a standard text for postgraduate physicians in the UK and beyond, providing all information necessary for modern cancer management in one comprehensive but accessible volume. By inviting experts from a number of disciplines to share their knowledge, the editors have succeeded in delivering a truly integrated approach to the care of the patient with cancer.



This fifth edition adopts the successful structure of previous editions, whilst being thoroughly revised and updated, and with several completely new chapters, covering important topics such as drug development, cancer prevention, and economics of cancer care, as well as treatments such as radioimmunotherapy, biological therapies and antibody therapy.



Part One considers the scientific basis and fundamental principles underlying cancer treatment and examines the likely developments that will occur over the next decade at the leading edge of oncology. Part Two is divided into two sections; the first covering general issues of cancer management, including planning techniques, concomitent chemoradiotherapy, surgical oncology and palliative care; and the second using a system-based approach to cover the clinical aspects and management plans for the whole spectrum of malignant disease.



Treatment of Cancer surpasses other oncology texts in condensing the essential information for exemplary cancer care into one readable and accessible guide, and will be an invaluable addition to the bookshelves of the busy oncologist in training or in practice.

• A comprehensive guide to modern cancer treatment
• Supports an integrated approach to patient care, involving radiotherapy, chemotherapy and surgery where appropriate
• Incorporates scientific discoveries with the best of current practice in a single volume
• New chapters for the 5th edition include cancer vaccines, radioimmunotherapy, antibody therapy, drug development, late effects and surgical oncology
• Learning points and key references highlighted in each chapter to aid revision and wider reading.

Table of Contents:
1. Introduction
2. Molecular biology
3. Clinical radiobiology
4. Mathematical modelling and its application in radiation oncology
5. Principles of chemotherapy and drug development
6. Tumour imaging in oncology
7. Interventional radiology
8. Cancer vaccines
9. Biological therapies: cytokines and adoptive cell therapy
10. Radioimmunotherapy
11. Monoclonal antibodies and treatment of cancer
12. Angiogenesis as a target for the treatment of cancer
13. Gene therapy
14. Central nervous system
15. Ocular and adnexal tumours
16. Head and neck cancer
17. Thyroid
18. Endocrine cancer
19. Breast cancer
20. Bronchus
21. Oesophageal cancer
22. Liver
23. Pancreas
24. Biliary Tract
25. Stomach
26. Bladder
27. Prostate
28. Colectoral cancer
29. Anus
30. Germ cell cancers of the testis and related neoplasms
31. Renal cell cancer
32. Ovary and fallopian tubes
33. Uterus
34. Cervix
35. Carcinoma of the vagina and vulva
36. Gestational trophoblastic tumours
37. Non-melonoma skin cancer
38. Malignant melanoma
39. Bone
40. Soft tissue sarcomas
41. Leukaemias
42. Hodgkin's lymphoma
43. Non-Hodgkin's lymphoma
44. Multiple myeloma
45. Introduction to haemotopoietic stem cell transplantation
46. Paediatric oncology
47. AIDS-related cancer
48. Medical Care
49. Interstitial brachytherapy
50. Principles of external beam radiotherapy planning tehniques
51. Conformal radiotherapy, intensity-modulated radiotherapy and image-guided radiotherapy
52. Concomitant chemo-radiotherapy principles and management
53. Palliative Care
54. Communications with the cancer patient
55. Clinical cancer genetics
56. Large-scale randomised evidence: trials and overviews
57. The economics of cancer care
58. Medical Audit
59. The organisation of cancer services: a UK perspective
60. New drug develoment
61. Late effects of cancer therapy
62. Surgical oncology
63. Cancer prevention strategies

About the Author(s):
PAT PRICE: Professor of Radiation Oncology, Academic Department of Radiation Oncology, School of Cancer and Imaging Sciences, Christie Hospital and University of Manchester, Manchester, UK.

KAROL SIKORA: Medical Director, Cancer Partners UK and Visiting Professor of Cancer Medicine, Imperial College, Hammersmith Hospital, London, UK.

TIM ILLIDGE: Professor of Targeted Therapy and Oncology, School of Cancer and Imaging Sciences, Christie Hospital and University of Manchester, Manchester, UK.

Readership:
Oncologists in training (MRCP / FRCR) and in practice. (Clinical oncologists [radiotherapists] and medical oncologists)